Yield10 Bioscience Inc (YTEN) Receives a Buy from Aegis Capital

By Jason Carr

In a report released today, James Jang from Aegis Capital maintained a Buy rating on Yield10 Bioscience Inc (YTENResearch Report), with a price target of $2. The company’s shares closed last Monday at $0.98.

Jang wrote:

“We expect a repeat on 2018 field trials with positive results, especially within C3003 in canola and camelina which should help YTEN pull forward collaboration with the company’s large AG major partners. In addition to canola and camelina, YTEN is also engaged with third parties interested in corn, soybean, wheat, and rice. The “Trait Factory” is helping to broaden YTEN’s product portfolio. The company has identified three new sectors which could present additional opportunities for for long-term growth; PHA Pharmaceuticals (CBD). We believe the company’s broadening of its core assets as a positive. YTEN expects commercialization could occur within six years, as discussions are ongoing with possible partners.”

According to TipRanks.com, Jang is ranked #4228 out of 5234 analysts.

Currently, the analyst consensus on Yield10 Bioscience Inc is a Strong Buy with an average price target of $2.50, a 108.3% upside from current levels. In a report released today, National Securities Corp also reiterated a Buy rating on the stock.

See today’s analyst top recommended stocks >>

The company has a one-year high of $1.77 and a one-year low of $0.68. Currently, Yield10 Bioscience Inc has an average volume of 132.7K.

Based on the recent corporate insider activity of 7 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of YTEN in relation to earlier this year.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.